Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
Allinky Biopharma
Allinky Biopharma
 
Type
PYME
Public entity
Contact
Miguel Vega. CEO
Mobile Phone: 34 618060829
lab@allinky.com
http://www.allinky.com
Activity
Scientific and clinical research have shown that sustained oxidative stress, chronic inflammatory condition and progression cell missignalling are key factors in diseases such as Alzheimer's, ictus, rheumatoid arthritis, osteoarthritis, diabetes type II, atherosclerosis and certain types of cancer. Allinky develops novel therapeutics capable of modulating abnormal cell-molecular signals behind these diseases and thus contributing to restore normal cell-gene expression. Therefore, Allinky seeks to become a well-known player in the application of molecular-based medicine to fight prevalent diseases.
Projects
Drug discovery and development of allosteric kinase modulators and protein-protein binding inhibitor for chronic inflammatory diseases, as well as metabolic and CNS diseases.
Permalink: http://www.mercadosbiotecnologicos.com/?eid=18&etid=1&lan=en

Search